Aller au contenu principal
Accès ouvert déclaré 2025 article

Weight gain following a diagnosis of anti-neutrophil cytoplasmic antibody-associated vasculitis

0Citations signalées, ce qui n’est pas une note de qualité
3Institutions déclarées
2Pays d’affiliation déclarés

Rattachement africain : au, gb. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

Abstract Objectives The prevalence of obesity in ANCA-associated vasculitis (AAV) has not been well documented, despite an increased risk of cardiometabolic disease in these patients. We aimed to characterize changes in weight following a diagnosis of AAV and determine risk factors for gaining weight and becoming obese. Methods We examined data from a single-centre registry of patients with AAV, diagnosed between 2003 and 2023. We evaluated changes in weight and BMI following diagnosis and determined the prevalence of obesity. Using linear regression, we identified factors contributing to an increase in BMI at 6 months. Logistic regression was used to define predictors for obesity at 6 months. Results A total of 215 patients with AAV were included. Patients experienced a mean weight gain of 5.2% in the first 6 months; this was sustained for at least 2 years. A total of 69% of patients were overweight or obese at 6 months compared with 59% at baseline. Weight gain was greater following the first presentation compared with relapsing disease. Baseline factors associated with an increase in BMI at 6 months included higher eGFR [β = 0.70 (95% CI 0.36, 1.03), P < 0.001] and earlier year of presentation [β = 0.38 (95% CI 0.08, 0.69), P = 0.008]. Higher eGFR [adjusted odds ratio (aOR) 1.36 (95% CI 1.08, 2.72), P < 0.001] and baseline BMI [aOR 2.57 (95% CI 1.81, 3.64), P < 0.001] were associated with an increased likelihood of obesity at 6 months. Conclusion Weight gain is common following a diagnosis of active AAV. This is now less pronounced than it was 2 decades ago. Better kidney function and higher baseline BMI are associated with a greater risk of being obese at 6 months. Many patients with AAV are likely to benefit from interventions aimed at achieving a healthy weight.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Weight gain following a diagnosis of anti-neutrophil cytoplasmic antibody-associated vasculitis
Date Crossref
01/01/2025
Éditeur
Oxford University Press (OUP)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Où se fait cette recherche

  • Royal Adelaide Hospital Central and Northern Adelaide Renal and Transplantation Service pays non établi dans la notice
    Établissement de santé
  • Edinburgh Royal Infirmary pays non établi dans la notice
    Établissement de santé
  • University of Edinburgh Centre for Cardiovascular Science pays non établi dans la notice
    Université ou école supérieure
  • Department of Renal Medicine pays non établi dans la notice
    Institution

Central and Northern Adelaide Renal and Transplantation Service — Royal Adelaide Hospital, Edinburgh Royal Infirmary et Centre for Cardiovascular Science — University of Edinburgh, avec 1 autre affiliation.

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Vasculitis and related conditionsSystemic Sclerosis and Related DiseasesOtitis Media and Relapsing Polychondritis

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.